Waldenstrom macroglobulinemia (mak-roe-glob-u-lih-NEE-me-uh) is a rare type of cancer that begins in the white blood cells.
If you have Waldenstrom macroglobulinemia, your bone marrow produces too many abnormal white blood cells that crowd out healthy blood cells. The abnormal white blood cells produce a protein that accumulates in the blood, impairs circulation and causes complications.
Waldenstrom macroglobulinemia is considered a type of non-Hodgkin's lymphoma. It's sometimes called lymphoplasmacytic lymphoma.
Products & Services
Waldenstrom macroglobulinemia is slow growing and may not cause signs and symptoms for many years.
When they do occur, signs and symptoms may include:
- Easy bruising
- Bleeding from the nose or the gums
- Weight loss
- Numbness in your hands or feet
- Shortness of breath
- Changes in vision
When to see a doctor
Make an appointment with your doctor if you have any persistent signs and symptoms that worry you.
Get the latest health information from Mayo Clinic delivered to your inbox.
Subscribe for free and receive an in-depth guide to coping
with cancer, plus helpful advice on how to get a second opinion. You can unsubscribe at any
ErrorEmail field is required
ErrorInclude a valid email address
To provide you with the most relevant and helpful information, and understand which
information is beneficial, we may combine your email and website usage information with
other information we have about you. If you are a Mayo Clinic patient, this could
include protected health information. If we combine this information with your protected
health information, we will treat all of that information as protected health
information and will only use or disclose that information as set forth in our notice of
privacy practices. You may opt-out of email communications at any time by clicking on
the unsubscribe link in the e-mail.
Thank you for subscribing
Your in-depth coping with cancer guide will be in your inbox shortly. You will also
receive emails from Mayo Clinic on the latest about cancer news, research, and care.
If you don’t receive our email within 5 minutes, check your SPAM folder, then contact us
Sorry something went wrong with your subscription
Please, try again in a couple of minutes
It's not clear what causes Waldenstrom macroglobulinemia.
Doctors know that the disease begins with one abnormal white blood cell that develops errors (mutations) in its genetic code. The errors tell the cell to continue multiplying rapidly.
Because cancer cells don't mature and then die as normal cells do, they accumulate, eventually overwhelming production of healthy cells. In the bone marrow — the soft, blood-producing tissue that fills in the center of most of your bones — Waldenstrom macroglobulinemia cells crowd out healthy blood cells.
Waldenstrom macroglobulinemia cells continue trying to produce antibodies, as healthy white blood cells do, but instead they produce abnormal proteins that the body can't use. The protein immunoglobulin M (IgM) accumulates in the blood, impairs circulation and causes complications.
Factors that may increase your risk of Waldenstrom macroglobulinemia include:
- Being older. Waldenstrom macroglobulinemia can occur at any age, but it's most often diagnosed in adults 65 and older.
- Being male. Males are more likely to be diagnosed with Waldenstrom macroglobulinemia.
- Being white. White people are more likely to develop the disease, compared with people of other races.
- Having a family history of lymphoma. If you have a relative who has been diagnosed with Waldenstrom macroglobulinemia or another type of B-cell lymphoma, you may have an increased risk.
Waldenstrom macroglobulinemia care at Mayo Clinic
Aug. 18, 2020
- AskMayoExpert. Waldenstrom macroglobulinemia. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2017.
- Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed June 26, 2017.
- Hoffman R, et al. Waldenstrom macroglobulinemia and lymphoplasmacytic lymphoma. In: Hematology: Basic Principles and Practice. 6th ed. Philadelphia, Pa.: Saunders Elsevier; 2013. https://www.clinicalkey.com. Accessed June 26, 2017.
- Gertz MA. Waldenstrom macroglobulinemia: 2017 update on diagnosis, risk stratification and management. American Journal of Hematology. 2017;92:209.
- Warner KJ. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 14, 2017.
Products & Services